يعرض 1 - 20 نتائج من 65 نتيجة بحث عن '"Kuriki H."', وقت الاستعلام: 0.67s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المساهمون: Yale University ,, 2370972

    Relation: SWISS MEDICAL WEEKLY; Herbst R. S. , De Marinis F., Giaccone G., Stahel R., Reinmuth N., Vergnenegre A., Barrios C. H. , Morise M., Felip E., Andric Z., et al., "Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110", SWISS MEDICAL WEEKLY, 2020; vv_1032021; av_82abf7d1-8d49-4790-8cc7-858f5d725023; http://hdl.handle.net/20.500.12627/2857

  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal

    المساهمون: Kusumoto, S., Arcaini, L., Hong, X., Jin, J., Kim, W. S., Kwong, Y. L., Peters, M. G., Tanaka, Y., Zelenetz, A. D., Kuriki, H., Fingerle-Rowson, G., Nielsen, T., Ueda, E., Piper-Lepoutre, H., Sellam, G., Tobinai, K.

    وصف الملف: STAMPA

    Relation: info:eu-repo/semantics/altIdentifier/pmid/30341058; info:eu-repo/semantics/altIdentifier/wos/WOS:000455409800006; volume:133; issue:2; firstpage:137; lastpage:146; numberofpages:10; journal:BLOOD; http://hdl.handle.net/11571/1363154; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85059824372

  11. 11
    Academic Journal
  12. 12
    Report

    المساهمون: Yale University ,, 157791

    Relation: Herbst R. S. , de Marinis F., Giaccone G., Reinmuth N., Vergnenegre A., Barrios C. H. , Morise M., Felip E., Andric Z., Geater S., et al., "Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by SP142, SP263 and 22C3 PD-L1 immunohistochemistry (IHC) assays and by blood tumour mutational burden (bTMB): Results from the IMpower110 study", Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO), Geneva, İsviçre, 11 - 14 Aralık 2019, cilt.30, ss.62-63; vv_1032021; av_ecf1f604-7b9b-42b3-b8b3-b0f3eb4ac257; http://hdl.handle.net/20.500.12627/155536; 30

  13. 13
    Report

    المساهمون: Sarah Cannon Research Institute ,, 157508

    Relation: Spigel D., de Marinis F., Giaccone G., Reinmuth N., Vergnenegre A., Barrios C. H. , Morise M., Felip E., Andric Z. G. , Geater S., et al., "IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1-selected NSCLC", 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30, ss.915; vv_1032021; av_d798644e-bd92-4577-88b2-a9801deca3e6; http://hdl.handle.net/20.500.12627/142261; 30

  14. 14
    Conference
  15. 15
    Conference
  16. 16
    Academic Journal
  17. 17
    Academic Journal

    المساهمون: Institut de minéralogie et de physique des milieux condensés (IMPMC), Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Diderot - Paris 7 (UPD7)-Institut de Physique du Globe de Paris (IPG Paris)-Centre National de la Recherche Scientifique (CNRS), Department of Chemistry, Graduate School of Science and Engineering, Department of Chemistry, Magnétisme et Supraconductivité (NEEL - MagSup), Institut Néel (NEEL), Université Joseph Fourier - Grenoble 1 (UJF)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP)-Centre National de la Recherche Scientifique (CNRS)-Université Joseph Fourier - Grenoble 1 (UJF)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP)-Centre National de la Recherche Scientifique (CNRS), University of Edinburgh (Edin.)

    المصدر: ISSN: 1098-0121 ; EISSN: 1550-235X.

  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal